SMTPs, a family of natural small molecules that effectively treat ischemic stroke, are subject to clinical development. SMTPs enhance plasminogen activation and inhibit soluble epoxide hydrolase (sEH), leading to promotion of endogenous thrombolysis and anti-inflammation. The SMTP molecule consists of a tricyclic γ-lactam moiety, an isoprene side-chain, and an N-linked side-chain. Here, we investigate the yet-to-be-characterized function of the isoprene sidechain of SMTPs in sEH inhibition and cellular distribution. The results demonstrated that oxidative modification as well as truncation of the side-chain abolished epoxide hydrolase inhibition. The introduction of a terminal hydroxy group exceptionally unaffected epoxide hydrolase, but led to impaired cellular localization, resulting in diminution of cellular epoxide hydrolase inhibition. Thus, the isoprene side-chain of SMTP is an important pharmacophore for epoxide hydrolase inhibition and cellular localization.
SMTPs are a family of triprenyl phenol metabolites from the fungus Stachybotrys microspora [1] . SMTPs facilitate plasminogen activation through modulation of closed plasminogen conformation to an activation-prone one [1] [2] [3] . SMTP-7, one of the family of compounds, thus promotes physiological plasmin formation and clot clearance in vivo [2, 4] . SMTP-7 effectively treats embolic/thrombotic stroke in rodent and primate models [5] [6] [7] . Noteworthy, it suppresses hemorrhagic transformation following ischemia/reperfusion [8] . Anti-inflammatory action of SMTP is postulated to account for this activity [9, 10] . We recently identified a responsible target as soluble epoxide hydrolase (sEH) [11] . sEH is a bifunctional enzyme that has a C-terminal epoxide hydrolase domain (Cterm-EH) and an N-terminal lipid phosphate phosphatase domain (Nterm-phos) [12, 13] . Cterm-EH converts antiinflammatory epoxy fatty acids such as epoxyeicosatrienoic acid (EET) to their corresponding diols (such as dihydroxyeicosatrienoic acid; DHET), thereby diminishing their beneficial antiinflammatory properties [14] . On the other hand, Nterm-phos hydrolyzes lipid phosphates such as lysophosphatidic acid and intermediates of the cholesterol biosynthesis [15] [16] [17] .
The SMTP molecule consists of a tricyclic γ-lactam moiety, an isoprene side-chain, and an N-linked side-chain. The N-linked sidechain is an important pharmacophore that affects plasminogen modulation activity [2, 18, 19] as well as sEH inhibition [11, 20] . The function of the isoprene side-chain, on the other hand, remains to be elucidated. SMTP-0, which lacks the N-linked side-chain, is inert in plasminogen modulation but is potent in sEH inhibition [11] , and it can serve as an ideal molecule to study the function of the isoprene side-chain in sEH inhibition. In the present study, we isolated SMTP-0 derivatives with modified isoprene side-chains and evaluated their structure-activity relationships.
To investigate the role of the isoprene side-chain in the inhibition of sEH, we produced seven new derivatives of SMTP-0 ( Figure 1 ) through conversion by microorganisms. SMTP-0a (1), SMTP-0d (4), and SMTP-0e (5) are hydroxylated derivatives, and SMTP-0b (2), SMTP-0c (3), SMTP-0f (6), and SMTP-0g (7) are carboxylated derivatives with varying side-chain length. The production of these compounds is summarized in the Supporting information SI.
The physicochemical properties and NMR spectral data of the newly isolated derivatives are shown in Tables 1 and 2 , as well as in the Supporting information (SI 2-SI 8). The structures of each derivative were elucidated based on the combination of these spectroscopic data. In the NMR spectra of 1, signals corresponding to positions 20-23 of SMTP-0 were not found. Instead, δ C 62.6 and δ H 3.49 (2H, t, J = 6.6) were observed. In combination with the MS data, we assigned these signals as a function of CH 2 OH at position-20. Signals corresponding to positions 18-23 of SMTP-0 were missing in the NMR spectra of 2, while δ C 180.8 was observed. In the NMR spectra of 3, the signal of C22 of SMTP-0 (δ C 25.3) was changed to δ C 172.3. These signals were assigned as a carboxy group at position 19 in 2 and position 22 in 3. In the NMR spectra for 4, signals at position 24 (δ C 59.8; δ H 4.06, 2H, brs) were different from those of SMTP-0 (δ C 15.5; δ H 1.54, 3H, s). Thus, the function at position 22 of 4 was assigned as CH 2 OH. Compound 5 has signals at δ C 79.0; δ H 3.17 (1H, d, J = 10.2) and δ C 73.8 instead of δ C 124.0; δ H 5.04 (1H, t, J = 7.1) and δ C 130.5 at positions 20 and 21 in SMTP-0, thus letting us to elucidate a 20,21-diol structure for 5.
Compound 6 lacked signals corresponding to positions 20-23 of SMTP-0, but had a signal at δ C 177.5, which was assigned as 20-COOH. Compound 7 lacked signals corresponding to positions 16-24 of SMTP-0, but had a signal at δ C 177.8, which was assigned as 16-COOH. All of these assignments were supported by the MS, as well as HMBC and HMQC data (Supporting information SI 9). Based on these observations, the structure of the new derivatives of SMTP-0 was determined as shown in Figure 1 . Molecular formula SMTP-0 inhibits both of the two catalytic activities of sEH in a distinct manner: the inhibition of Cterm-EH is competitive and that of Nterm-phos is noncompetitive [11] . Therefore, we investigated the structure-activity relationships of the newly isolated derivatives regarding Cterm-EH and Nterm-phos of sEH ( Figure 2A ). The inhibition (IC 50 ) of Cterm-EH and Nterm-phos of mouse sEH (m-sEH) by SMTP-0 was 6 ± 1 and 14 ± 1 µM, respectively [11] . As shown in Figure 2A , compound 1, which has a hydroxy group at the terminus of the isoprene side-chain, lost activity in Nterm-phos inhibition (IC 50 192 ± 5 µM) while retaining inhibitory activity toward Cterm-EH (IC 50 10 ± 0 µM). Thus, 1 has a ~20-fold selectivity toward Cterm-EH compared with Nterm-phos.
Compound 5, which has a diol structure at the terminus of the sidechain, was much weaker than 1, but was selective to Cterm-EH (IC 50 96 ± 19 µM, compared with > 500 µM for Nterm-phos). Compound 4, which has a hydroxyl group at the middle of the sidechain, had a reduced activity for Cterm-EH inhibition (IC 50 62 ± 8 µM) compared with 1 (with a terminal hydroxy group), whereas 5 was more active than 1 with respect to Nterm-phos inhibition (IC 50 81 ± 6 µM). Thus, regarding the derivatives with a hydroxyl group(s) in the isoprene side-chain, it is likely that a terminal hydroxyl group contributes to selectivity for Cterm-EH inhibition, while increasing the number of hydroxyl groups reduces inhibitory activity. In addition, the position of the hydroxy group in the sidechain affects potency and selectivity. The carboxylation of the sidechain resulted in a decrease in inhibitory activities for both Cterm-EH and Nterm-phos as exemplified by 3. Truncation of the sidechain caused decreases in inhibitory activities depending on the chain length. Thus, changing the isoprene side-chain of SMTP potently alters the inhibitory potency with respect to both sEH enzymes and selectivity on Cterm-EH.
SMTP-0 was also inhibitory to Ctem-EH of recombinant human sEH (rh-sEH) (IC 50 of 5 ± 1 µM). Therefore, we additionally compared Cterm-EH inhibition between m-sEH and rh-sEH ( Figure  2B ). The potency of most of the derivatives was almost the same toward m-sEH and rh-sEH, while the activity of 5 was relatively selective to rh-sEH (IC 50 34 ± 2 for rh-sEH vs. 135 ± 18 for m-sEH). This information may help designing an SMTP congener specific for human sEH.
We next examined the activity of 1, which has a distinct structural feature but retaining significant activity to inhibit Cterm-EH compared with SMTP-0 in in vitro enzyme assay ( Figure 3A) . When tested for inhibition of cellular Cterm-EH using HepG2 cells, inhibitory activity of cellular Cterm-EH (measured as the conversion of 14,15-EET to 14,15-DHET) by 1 was < 1/70 of that of SMTP-0 ( Figure 3B ). We speculated that 1 did not penetrate into the lipid bilayer membrane of the cells or is prone to dissociate from cellular membrane or cellular compartment due to the hydrophilic hydroxyl group at the terminus of the isoprene side-chain. To test this hypothesis, we treated HepG2 cells with the two congeners with or without washing after the treatment, and compared their amount in cell-associated or supernatant fractions. The result demonstrated that the amount of 1 in the cell-associated fraction was significantly smaller than that of SMTP-0 ( Figure 3C) . Thus, the present study demonstrates that oxidative modification of the isoprene side-chain of SMTP-0 dramatically affects its activity toward inhibition of Cterm-EH and Nterm-phos of sEH. In a cell-based assay, it is suggested that 1, which has a hydrophilic hydroxy group at the terminus of its isoprene side-chain, does not penetrate nor readily dissociate from the cellular membrane or cellular compartment. It is likely that the hydrophobic isoprene side-chain plays a role in providing a cell-compatible interfacial equilibrium. Taken together, 226 Natural Product Communications Vol. 11 (2) 2016
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the isoprene side-chain of SMTP is a critical determinant of sEH inhibition and cellular localization.
Experimental

Identification of fungal strains that can derivatize SMTP-0:
Approximately 500 fungal strains were screened for their ability to derivatize SMTP-0. Fungal strains were inoculated in 100 mL baffled flasks containing 20 mL of medium A (glucose (3.5%), corn starch (1%), soybean meal (2%), peptone (0.5%), fish extract (0.5%), yeast extract (0.2%), NaCl (0.2%), K 2 HPO 4 (0.05%), MgSO 4 ･7H 2 O (0.005%), and the antifoam CB442 (Nippon Oil & Fat Co.) (0.01%), pH 5.8), and incubated at 25°C on a rotary shaker at 180 rpm for 4 days. On day 4, SMTP-0 (20 mg in acetone) was added to each flask, and the culture was incubated further to monitor the formation of a derivative using HPLC. The active strains, F039 and F388 were soil isolates (collected at Sengendai-Park, Fuchu, Tokyo (N 35°40'52"1907, E 139°30'08"5411) in April 2010. Another active strain was Phialophora heteromorpha IFO 6871, which was obtained from the Institute of Fermentation, Osaka, Japan.
Production and isolation of derivatives of SMTP-0: Compound 1
was produced by a strain of F039. The strain was inoculated to a 500 mL baffled flask containing 100 mL of medium A. After incubation at 25°C for 4 days on a rotary shaker at 180 rpm, aliquots of the resulting culture (5 mL) were transferred to four 500 mL baffled flasks containing 100 mL of medium A. After incubation for 3 days, 100 mg of SMTP-0 was added to each flask as a 1 mL of acetone solution, and the flasks were incubated further for 4 days. Compounds 2 and 3 were produced by the strain of F388. This strain was grown as described above in 5 baffled flasks. After 2 days, 100 mg of SMTP-0 was added to each flask, and the incubation was continued for a further 5 days. Compounds 4 and 5 were metabolites of SMTP-0 produced by extending the culture period from 1 day (following ammonium chloride feeding) for the production of SMTP-0 to 8 days for conversion. Compounds 6 and 7 were produced by P. heteromorpha IFO 6871 by incubating in medium A, as described for the production of 2 or 3. The incubation time after the addition of SMTP-0 was 1 day for the production of 6 and 11 days for 7. Each of the cultures was extracted with 200 mL of methanol, and the resulting MeOH extracts were concentrated and extracted with EtOAc for purification of derivatives, except 7, which was directly purified from the MeOH extract.
For the isolation of 1, the EtOAc extract was subjected to preparative HPLC on an Inertsil PREP-ODS (30 × 250 mm, GL Science, Tokyo, Japan) developed with a linear gradient of MeOH in 0.1% formic acid (10-100% for 30 min) at 25 mL −1 min at 40°C (condition A). Compound 1 appeared as a peak at a retention time of 22.3 min. The fraction was concentrated to dryness. The resulting material was subjected to repeated preparative HPLC developed with 50% CH 3 CN in 0.1% formic acid. The fraction containing 1 (retention time of 19.2 min) was collected and concentrated to dryness, affording 32.3 mg of powder, which was subjected to preparative HPLC developed with 50% MeOH in 0.1% ammonium acetate. The fraction at a retention time of 16.0 min was concentrated to dryness, affording 19.5 mg of 1.
For the isolation of 2, the aqueous fraction of EtOAc extraction was subjected to chromatography on Diaion HP-20 (Mitsubishi Chemical, Tokyo, Japan) equilibrated with water and developed with 50% MeOH in water. The resulting eluate was concentrated to dryness, which was then subjected to preparative HPLC under condition A. The fraction at a retention time of 20 min was concentrated and subjected to a second HPLC fractionation developed with 20% CH 3 CN in 0.1% formic acid. The fraction at a retention time of 22 min afforded 10.6 mg of 2.
For the isolation of 3, the EtOAc extract was subjected to preparative HPLC developed with a linear gradient of MeOH in 0.1% formic acid (50-100% for 30 min) at 25 mL −1 min at 40°C (condition B). The fraction at a retention time of 26.5 min was concentrated, and subjected to a second HPLC fractionation developed with 30% CH 3 CN in 0.1% formic acid. The fraction at a retention time of 37 min afforded 8.4 mg of 3.
For the isolation of 5 and 4, the EtOAc extract was subjected to preparative HPLC under condition B, excepting that the gradient elution was started from 50% MeOH. The fractions at retention times of 5, 12, and 20 min were concentrated, and the first two fractions were combined and subjected to a second HPLC purification step developing with 45% MeOH in 0.1% formic acid. The fraction at a retention time of 31 min was further purified by HPLC developed with 25% CH 3 CN in 0.1% formic acid, affording 18.8 mg of 5 from the fraction at a retention time of 19 min. The third fraction in the first HPLC was further purified by HPLC developed with 60% MeOH in 0.1% formic acid. The fraction at a retention time of 29 min afforded 23.7 mg of 4.
For the isolation of 6, the EtOAc extract was subjected to preparative HPLC developed with 45% MeOH in 0.1% formic acid. The fraction at a retention time of 25 min was further subjected to HPLC developed with 25% CH 3 CN in 0.1% formic acid. The fraction at a retention time of 19 min afforded 18.5 mg of 6.
For the isolation of 7, the MeOH extract of the culture was directly subjected to preparative HPLC developed with 25% MeOH in 0.1% formic acid. The fraction at a retention time of 18 min afforded 34.4 mg of 7.
Assay for sEH: rh-sEH was obtained from Cayman Chemical (Ann Arbor, MI, USA). m-sEH was purified as described previously [11] . The activities of Cterm-EH and Nterm-phos were assayed as described previously [11] using 3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester (PHOME; Cayman Chemical) and AttoPhos (Promega, Madison, WI, USA) as respective substrates. Cterm-EH was assayed using both m-sEH and rh-sEH. The enzyme (60 ng for m-sEH and 30 ng for rh-sEH) was preincubated for 10 min in 80 µL of 25 mM Bis-Tris-HCl, pH 7.0, containing 0.1 mM MgCl 2 and 0.1 mg mL −1 bovine serum albumin (buffer A) with or without a compound to be tested. After adding 20 µL of PHOME (final concentration of 12.5 µM), fluorescence (excitation, 355 nm; emission, 460 nm) of the reaction product was measured kinetically at 30°C. The Nterm-phos activity was assayed using only m-sEH, since the activity of rh-sEH was very low. M-sEH (30 ng) was preincubated for 10 min in 80 µL of buffer A with or without a compound to be tested. After adding 20 µL of AttoPhos (final concentration of 5 µM), fluorescence (excitation, 450 nm; emission, 545 nm) of the reaction product was measured kinetically at 30°C. Compounds to be tested were dissolved in DMSO, and the final concentrations of DMSO in these assays were 0.5%.
Assay for Cterm-EH in cultured cells: HepG2 cells (5 × 10 4 cells)
were seeded on 24-well plates and cultured overnight. Cells were then washed with Hanks' balanced salt solution containing 20 mM Hepes, pH 7.4, 0.1 mg mL -1 bovine serum albumin, and 1 mM MgCl 2 (buffer B) and subsequently treated with indicated concentrations of either SMTP-0 or 1 in 500 µL of buffer B for 10 min. After addition of 14,15-EET (0.3 µM) to the culture for
